Clinical trialNCT02227797CompletedPhase 1Interventional

MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients

SponsorMasonic Cancer Center, University of MinnesotaEnrollment66Fungal Infection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary purpose of this study is to identify the optimal dose of voriconazole, an anti-fungal drug often used in people undergoing stem cell transplant. An optimal dose level is one level that provides a good blood level (concentration) of voriconazole without too much toxicity.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Angela Smith, M.D.
Masonic Cancer Center, University of Minnesota
Principal Investigator
clinicaltrials.gov ↗
Pui-Yang Iroh Tam, M.D.
Masonic Cancer Center, Univeristy of Minnesota
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Minnesota Medical Center, Fairview
Minneapolis, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Voriconazole →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jan 2015
Primary completion: 8 Sept 2017
Completion: 1 Mar 2019
Last update posted: 29 Apr 2019
Registered enrollment: 66
Registry id: NCT02227797

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.